rs150077735
Variant summary
Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_005236.3(ERCC4):c.2734G>A(p.Gly912Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0000658 in 1,611,460 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G912E) has been classified as Uncertain significance.
Frequency
Consequence
NM_005236.3 missense
Scores
Clinical Significance
Conservation
Publications
- xeroderma pigmentosum group FInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P, ClinGen
- Fanconi anemia complementation group QInheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- XFE progeroid syndromeInheritance: AR Classification: STRONG Submitted by: Ambry Genetics
- Fanconi anemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- xeroderma pigmentosumInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- xeroderma pigmentosum-Cockayne syndrome complexInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -13 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_005236.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ERCC4 | NM_005236.3 | MANE Select | c.2734G>A | p.Gly912Arg | missense | Exon 11 of 11 | NP_005227.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ERCC4 | ENST00000311895.8 | TSL:1 MANE Select | c.2734G>A | p.Gly912Arg | missense | Exon 11 of 11 | ENSP00000310520.7 | ||
| ERCC4 | ENST00000682617.1 | c.2872G>A | p.Gly958Arg | missense | Exon 12 of 12 | ENSP00000507912.1 | |||
| ERCC4 | ENST00000389138.7 | TSL:2 | n.2011G>A | non_coding_transcript_exon | Exon 6 of 6 |
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152100Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000214 AC: 53AN: 247552 AF XY: 0.000194 show subpopulations
GnomAD4 exome AF: 0.0000624 AC: 91AN: 1459242Hom.: 2 Cov.: 33 AF XY: 0.0000496 AC XY: 36AN XY: 726054 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000985 AC: 15AN: 152218Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74430 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1Other:1
not provided Uncertain:1
The ERCC4 p.Gly912Arg variant was not identified in the literature nor was it identified in Cosmic or LOVD 3.0. The variant was identified in dbSNP (ID: rs150077735) and ClinVar (classified as likely benign by Invitae). The variant was identified in control databases in 58 of 264586 chromosomes (1 homozygous) at a frequency of 0.0002192 (Genome Aggregation Database March 6, 2019, v2.1.1, non-cancer). The variant was observed in the following populations: East Asian in 57 of 19170 chromosomes (freq: 0.002973) and Latino in 1 of 35058 chromosomes (freq: 0.000029), but was not observed in the African, Ashkenazi Jewish, European (Finnish), European (non-Finnish), Other, or South Asian populations. The p.Gly912 residue is conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) provide inconsistent predictions regarding the impact to the protein; this information is not very predictive of pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance.
Cockayne syndrome;C0268140:Xeroderma pigmentosum, group F;C3808988:Fanconi anemia complementation group Q Benign:1
Xeroderma pigmentosum, group F Benign:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at